A retrospective review of outcome and survival following surgery and adjuvant xenogeneic DNA vaccination in 32 dogs with oral malignant melanoma

A xenogeneic DNA vaccination has been licensed for use in dogs with locally controlled stage II and III oral malignant melanoma (OMM). At present, there are limited outcome data for dogs with OMM treated with surgery and immunotherapy. The aim of this study is to retrospectively review the outcome a...

Descripción completa

Detalles Bibliográficos
Autores principales: TREGGIARI, Elisabetta, GRANT, Jessica Pauline, NORTH, Susan Margaret
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Veterinary Science 2016
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905841/
https://www.ncbi.nlm.nih.gov/pubmed/26781703
http://dx.doi.org/10.1292/jvms.15-0510

Ejemplares similares

Ejemplares similares